Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2015 | ||||
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine | 2015 | |||
Sofosbuvir plus ribavirin for 12 16 or 24 weeks results in sustained virologic response over 97% in genotype 1 and 6 HCV infection in Hong Kong Proceeding/Conference:Hepatology International | 2015 | 110 |